111 related articles for article (PubMed ID: 28072581)
1.
Barquero R; Garcia HP; Incio MG; Minguez P; Cardenas A; Martínez D; Lassmann M
Phys Med Biol; 2017 Feb; 62(3):909-926. PubMed ID: 28072581
[TBL] [Abstract][Full Text] [Related]
2. Monte Carlo modeling of gamma cameras for I-131 imaging in targeted radiotherapy.
Autret D; Bitar A; Ferrer L; Lisbona A; Bardiès M
Cancer Biother Radiopharm; 2005 Feb; 20(1):77-84. PubMed ID: 15778585
[TBL] [Abstract][Full Text] [Related]
3. Septal penetration correction in I-131 imaging following thyroid cancer treatment.
Barrack F; Scuffham J; McQuaid S
Phys Med Biol; 2018 Mar; 63(7):075012. PubMed ID: 29465414
[TBL] [Abstract][Full Text] [Related]
4. Our solution for fusion of simultaneusly acquired whole body scintigrams and optical images, as usesful tool in clinical practice in patients with differentiated thyroid carcinomas after radioiodine therapy. A useful tool in clinical practice.
Matovic M; Jankovic M; Barjaktarovic M; Jeremic M
Hell J Nucl Med; 2017; 20 Suppl():159. PubMed ID: 29324929
[TBL] [Abstract][Full Text] [Related]
5. Acquisition settings for PET of 124I administered simultaneously with therapeutic amounts of 131I.
Lubberink M; van Schie A; de Jong HW; van Dongen GA; Teule GJ
J Nucl Med; 2006 Aug; 47(8):1375-81. PubMed ID: 16883019
[TBL] [Abstract][Full Text] [Related]
6. Influence of high-energy photons on the spectrum of iodine-123 with low- and medium-energy collimators: consequences for imaging with 123I-labelled compounds in clinical practice.
Dobbeleir AA; Hambÿe AS; Franken PR
Eur J Nucl Med; 1999 Jun; 26(6):655-8. PubMed ID: 10369952
[TBL] [Abstract][Full Text] [Related]
7. Collimator and energy window optimization for ⁹⁰Y bremsstrahlung SPECT imaging: A SIMIND Monte Carlo study.
Roshan HR; Mahmoudian B; Gharepapagh E; Azarm A; Pirayesh Islamian J
Appl Radiat Isot; 2016 Feb; 108():124-128. PubMed ID: 26720261
[TBL] [Abstract][Full Text] [Related]
8. A Monte Carlo study on (223)Ra imaging for unsealed radionuclide therapy.
Takahashi A; Miwa K; Sasaki M; Baba S
Med Phys; 2016 Jun; 43(6):2965-2974. PubMed ID: 27277045
[TBL] [Abstract][Full Text] [Related]
9. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
Seo Y; Wong KH; Sun M; Franc BL; Hawkins RA; Hasegawa BH
J Nucl Med; 2005 May; 46(5):868-77. PubMed ID: 15872362
[TBL] [Abstract][Full Text] [Related]
10. Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I.
Hilditch TE; Dempsey MF; Bolster AA; McMenemin RM; Reed NS
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):783-8. PubMed ID: 12029552
[TBL] [Abstract][Full Text] [Related]
11. Analytically based photon scatter modeling for a multipinhole cardiac SPECT camera.
Pourmoghaddas A; Wells RG
Med Phys; 2016 Nov; 43(11):6098. PubMed ID: 27806581
[TBL] [Abstract][Full Text] [Related]
12. High Level of Agreement Between Pretherapeutic 124I PET and Intratherapeutic 131I Imaging in Detecting Iodine-Positive Thyroid Cancer Metastases.
Ruhlmann M; Jentzen W; Ruhlmann V; Pettinato C; Rossi G; Binse I; Bockisch A; Rosenbaum-Krumme S
J Nucl Med; 2016 Sep; 57(9):1339-42. PubMed ID: 27151981
[TBL] [Abstract][Full Text] [Related]
13. Reference-free thyroid uptake measurement.
Shapiro B; Zanin DE; Schipper R
Nucl Med Commun; 2014 Apr; 35(4):382-90. PubMed ID: 24569705
[TBL] [Abstract][Full Text] [Related]
14. Monte Carlo simulation of energy spectra for (123)I imaging.
Tanaka M; Uehara S; Kojima A; Matsumoto M
Phys Med Biol; 2007 Aug; 52(15):4409-25. PubMed ID: 17634641
[TBL] [Abstract][Full Text] [Related]
15. Influence of positron emitters on standard γ-camera imaging.
Jødal L; Afzelius P; Jensen SB
J Nucl Med Technol; 2014 Mar; 42(1):42-50. PubMed ID: 24470597
[TBL] [Abstract][Full Text] [Related]
16. Influence of high-energy photons from cobalt-57 flood sources on scintillation camera uniformity images.
Sokole EB; Heckenberg A; Bergmann H
Eur J Nucl Med; 1996 Apr; 23(4):437-42. PubMed ID: 8612665
[TBL] [Abstract][Full Text] [Related]
17. Dose-Response Relationship in Differentiated Thyroid Cancer Patients Undergoing Radioiodine Treatment Assessed by Means of 124I PET/CT.
Wierts R; Brans B; Havekes B; Kemerink GJ; Halders SG; Schaper NN; Backes WH; Mottaghy FM; Jentzen W
J Nucl Med; 2016 Jul; 57(7):1027-32. PubMed ID: 26917706
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET.
Eschmann SM; Reischl G; Bilger K; Kupferschläger J; Thelen MH; Dohmen BM; Besenfelder H; Bares R
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):760-7. PubMed ID: 12029549
[TBL] [Abstract][Full Text] [Related]
19. Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer.
Jentzen W; Freudenberg L; Eising EG; Sonnenschein W; Knust J; Bockisch A
J Nucl Med; 2008 Jun; 49(6):1017-23. PubMed ID: 18483099
[TBL] [Abstract][Full Text] [Related]
20. Pretherapeutic dosimetry in patients affected by metastatic thyroid cancer using 124I PET/CT sequential scans for 131I treatment planning.
Pettinato C; Spezi E; Nanni C; Grassetto G; Monari F; Allegri V; Civollani S; Cima S; Zagni P; Mazzarotto R; Colletti PM; Rubello D; Fanti S
Clin Nucl Med; 2014 Aug; 39(8):e367-74. PubMed ID: 24978332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
